Fenspiride efficacy in the treatment of chronic obstructive pulmonary disease
Sign Up to like & getrecommendations! Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.oa1488
Abstract: Background : Current guidelines recommend bronchodilators (Beta2-agonists, Anticholinergics, Methylxanthines) in stable COPD, which do not possess direct anti-inflammatory properties. At the same time, the efficacy of drugs that diminish the inflammation of bronchial mucosa (Fenspirid)… read more here.
Keywords: efficacy treatment; treatment; disease; efficacy ... See more keywords